Trazodone (Trittico)

Subscribe to Selected New Research on Trazodone

428 relevant articles (53 outcomes, 64 trials/studies) found for this Drug

Description: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)

Also Known As:

Trittico; Desyrel; Thombran; Deprax; Molipaxin; AF-1161; Apo-Trazodone; Apotex Brand of Trazodone Hydrochloride; Apothecon Brand of Trazodone Hydrochloride; Aventis Brand of Trazodone Hydrochloride; Aventis Pharma Brand of Trazodone Hydrochloride; Boehringer Ingelheim Brand of Trazodone Hydrochloride; Bristol-Myers Squibb Brand of Trazodone Hydrochloride; Farma Lepori Brand of Trazodone Hydrochloride; Gen-Trazodone; Genpharm Brand of Trazodone Hydrochloride; Hexal Brand of Trazodone Hydrochloride; Novo-Trazodone; Novopharm Brand of Trazodone Hydrochloride; Nu-Pharm Brand of Trazodone Hydrochloride; Nu-Trazodone; PMS-Trazodone; Pharmascience Brand of Trazodone Hydrochloride; Ratiopharm Brand of Trazodone Hydrochloride; Searle Brand of Trazodone Hydrochloride; Sidmark Brand of Trazodone Hydrochloride; Tradozone; Trazodon Hexal; Trazodon-neuraxpharm; Trazodone Hydrochloride; Trazon; neuraxpharm Brand of Trazodone Hydrochloride; ratio-Trazodone; AF 1161; AF1161; Apo Trazodone; Bristol Myers Squibb Brand of Trazodone Hydrochloride; Gen Trazodone; Novo Trazodone; Nu Pharm Brand of Trazodone Hydrochloride; Nu Trazodone; PMS Trazodone; Trazodon neuraxpharm; ratio Trazodone; 1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

5,6,7,8-tetrahydrotrazodone

5-(1-hydroxyethyl)etoperidone

5-(1-oxoethyl)etoperidone

5,6,7,8-tetrahydrotrazodone

5-(1-hydroxyethyl)etoperidone

5-(1-oxoethyl)etoperidone

trazolan

Experts

1.	Saletu, Bernd: 3 articles (01/2005 - 02/2002)
2.	Anderer, Peter: 3 articles (01/2005 - 02/2002)
3.	Saletu-Zyhlarz, Gerda Maria: 3 articles (01/2005 - 02/2002)
4.	Dionisio, P: 2 articles (09/2006 - 08/2005)
5.	Olivieri, L: 2 articles (09/2006 - 08/2005)
6.	Di Loreto, G: 2 articles (09/2006 - 08/2005)
7.	Kasper, S: 2 articles (01/2006 - 08/2005)
8.	Zboralski, Krzysztof: 2 articles (08/2005 - 05/2005)
9.	Florkowski, Antoni: 2 articles (08/2005 - 05/2005)
10.	Gałecki, Piotr: 2 articles (08/2005 - 05/2005)

Related Diseases

1.	Sleep Initiation and Maintenance Disorders (Insomnia) 04/01/2005 - "DATA SYNTHESIS: Evidence for the efficacy of trazodone in treating insomnia is very limited; most studies are small, conducted in populations of depressed patients, raise issues of design, and often lack objective efficacy measures" 01/01/2003 - "Evaluation of the target symptoms of trazodone by ranking the most improved symptoms identified insomnia as the most improved psychopathological item in all three scales" 01/01/2005 - "After trazodone introduction, insomnia improved and the median (interquartile range) of this item in G1 and G2 patients showed no statistically significant difference on Day 28 (G1: 0 (0-1); G2: 0 (0-2))" 08/01/1983 - "In the subjective ratings, sleep improved in quality on trazodone, significantly so in the first and second weeks of intake, though with significant rebound insomnia on the second withdrawal night" 09/01/2005 - "Low-dose trazodone effective in insomnia." Order ALL the reference details at left...
2.	Erectile Dysfunction 08/01/2000 - "This study examined the efficacy of trazodone 200 mg/day in patients with erectile dysfunction (ED) without major organic findings" 06/01/1999 - "A placebo controlled, fixed dose, double-blind crossover study was performed to evaluate the safety and efficacy of oral trazodone for the treatment of erectile dysfunction" 09/01/1997 - "CONCLUSION: In a group of patients, that was not selected on the basis of the etiology of the erectile dysfunction, nor selected on the duration of the complaint, the efficacy of trazodone 150 mg/d, could not be shown." 08/01/2000 - "Trazodone: a double-blind, placebo-controlled, randomized study of its effects in patients with erectile dysfunction without major organic findings." 06/01/1999 - "Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial." Order ALL the reference details at left...
3.	Syndrome 06/01/1996 - "A survey of previous cases with organic brain syndromes who had aggressive behaviors and responded well to trazodone revealed that most of the cases were aged individuals and that cases in adolescence are rare." 08/01/2003 - "Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations." 01/01/1998 - "Serotonergic syndrome with trazodone." 08/01/1995 - "Treatment of organic personality syndrome with low-dose trazodone." 09/01/1986 - "Withdrawal syndrome in a depressed patient treated with trazodone." Order ALL the reference details at left...
4.	Dementia (Dementias) 01/01/2004 - "Frontotemporal dementia: a randomised, controlled trial with trazodone." 01/01/2004 - "In order to assess effectiveness and safety of trazodone, longer-term trials are needed, involving larger samples of participants with a wider variety of types and severities of dementia." 01/01/2004 - "SELECTION CRITERIA: All unconfounded, double-blind, randomised controlled trials, comparing trazodone with placebo in managing behavioural and psychiatric symptoms (except depression) in any type of dementia" 02/01/1993 - "In this equivalence study the effect of 5'-MTHF on depressive symptoms and cognitive status was compared to Trazodone (TRZ) in normofolatemic elderly patients with mild to moderate dementia and depression" 01/01/2004 - "REVIEWERS' CONCLUSIONS: There is insufficient evidence to recommend the use of trazodone as a treatment for behavioural and psychological manifestations of dementia" Order ALL the reference details at left...
5.	Pain (Aches) 01/01/1999 - "AIMS: An 8-week parallel, placebo-controlled, double-blind trial evaluated the efficacy of the antidepressant trazodone in the treatment of chronic burning mouth pain" 01/01/1999 - "CONCLUSION: In this controlled trial, trazodone failed to relieve burning mouth pain." 05/01/2003 - "CONCLUSIONS: The results suggest that a mainly serotonergic descending pain control pathway mediates the analgesic effects of trazodone." 05/01/2003 - "However, the analgesic effects of trazodone on neuropathic pain are controversial" 05/01/2003 - "BACKGROUND AND OBJECTIVE: Trazodone hydrochloride is used in the treatment of neuropathic pain" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Serotonin (5 Hydroxytryptamine)
2.	Antidepressive Agents (Antidepressants)
3.	Haloperidol (Haldol)
4.	Mianserin
5.	nefazodone (Serzone)
6.	Hypnotics and Sedatives (Sedatives)
7.	Imipramine (Janimine)
8.	Yohimbine (Yocon)
9.	Antipsychotic Agents (Antipsychotics)
10.	Alprazolam (Xanax)

Related Therapies and Procedures

1.	Activities of Daily Living (ADL)
2.	Hypnosis (Mesmerism)
3.	Complementary Therapies (Alternative Medicine)
4.	Continuous Positive Airway Pressure
5.	Tracheostomy

Best Treatments:
Research Summary Report
on Sleep Initiation and Maintenance Disorders

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 299 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>